Physician profile
James T Miller
NPI 1114373784
$868.15
in general payments reported to CMS, 2019-2025
17 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $17.75 · 2022: $128 · 2023: $251 · 2024: $106 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $478.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $80.09 | 2025 | Wegovy |
| Organon LLC | $71.94 | 2023-2024 | Nexplanon |
| Abbvie INC. | $67.38 | 2022-2023 | |
| Coopersurgical, INC. | $53.46 | 2022-2025 | Supercut Hysterectomy Scissors, Endosee |
| Sumitomo Pharma America, INC. | $47.05 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $46.73 | 2022 | |
| Minerva Surgical, INC | $44.05 | 2023-2024 | |
| Astellas Pharma US INC | $37.81 | 2023-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $32.09 | 2023 | |
| Medtronic, INC. | $22.33 | 2023 | Ligasure |
| Hologic Sales and Service, LLC | $21.96 | 2025 | Aptima, Thinprep 2000 Processor |
| Livanova USA, INC. | $20.95 | 2023 | Lifesparc |
| Glaxosmithkline, LLC. | $17.75 | 2020 | |
| Millicent US INC | $16.99 | 2024 | Femring, Intrarosa |
| Evofem Biosciences, INC. | $14.99 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $14.26 | 2024 | |
| Scynexis, INC. | $14.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.